Fezolinetant for the Improvement of Vasomotor Symptoms in Breast Cancer Patients Taking Endocrine Therapy, VENT Trial

Clinical trial NCT06617455 · TERMINATED

Trial details

NCT number: NCT06617455
Sponsor: University of Michigan Rogel Cancer Center
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Anatomic Stage I Breast Cancer AJCC v8 Anatomic Stage II Breast Cancer AJCC v8 Anatomic Stage III Breast Cancer AJCC v8 Breast Ductal Carcinoma In Situ Localized Breast Carcinoma

Start date: 2024-10-31
Primary completion: 2025-10-22
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.